Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam Inc
(NQ:
BEAT
)
2.820
-0.100 (-3.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heartbeam Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Seasoned Veteran as New Chief Medical Officer
October 11, 2022
Via
Investor Brand Network
HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer
October 11, 2022
From
HeartBeam, Inc.
Via
Business Wire
CapitalGainsReport: Sector Spotlight Medical Monitoring Stocks. (BEAT, DXCM, WHSI, NMRD, GBS)
October 11, 2022
Via
AB Newswire
BioMedNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
October 10, 2022
Via
Investor Brand Network
Exposures
Product Safety
Frequency of Bowel Movement Could Predict Heart Attack Risk
October 04, 2022
Via
Investor Brand Network
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
October 11, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...
Via
Benzinga
Beat Of Life Entertainment- A One Stop Solution For Internet Marketing
October 08, 2022
Internet marketing is the solution for business development in the digitalization era.
Via
IssueWire
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
Stocks Edge Lower As Bond Yields Rise
October 06, 2022
Wall Street is taking a step back, as sentiment wanes and bond yields rise.
Via
Talk Markets
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Platform to Add 24/7 Heart Monitoring Capability
October 06, 2022
Via
Investor Brand Network
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
Why Is HeartBeam (BEAT) Stock Up 24% Today?
October 06, 2022
HeartBeam (BEAT) stock is seeing gains on Thursday as investors react to news of it expanding its product portfolio pipeline.
Via
InvestorPlace
US Stocks Open Lower; Dow Drops Over 200 Points
October 06, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Thursday.
Via
Benzinga
HeartBeam (NASDAQ: BEAT) Unveils Cardiac Wearable Connectivity Feature that Can Turn Smartwatch Devices into Around-the-Clock Heart Monitoring Solutions
October 06, 2022
HeartBeam, Inc. (NASDAQ: BEAT) is engaged as a cardiac technology company, which leverages its line of proprietary algorithms to help
Via
Spotlight Growth
Topics
Intellectual Property
Exposures
Intellectual Property
Why Heartbeam Stock Is Surging Today
October 06, 2022
Heartbeam Inc (NASDAQ: BEAT) shares are surging Thursday morning after the company announced it expanded its product portfolio pipeline to include smartwatch connectivity, which will serve the growing...
Via
Benzinga
HeartBeam Broadens Product Portfolio Pipeline with Smartwatch Connectivity Enablement for 24/7 Heart Monitoring Solution
October 06, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues
October 03, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
HeartBeam, Inc. (NASDAQ: BEAT) Featured in Virtual Coverage of Dawson James Small Cap Growth Conference on October 12th
September 29, 2022
Via
Investor Brand Network
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Announces Participation in Two Investor Events
September 29, 2022
Via
Investor Brand Network
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 29, 2022
Gainers
Via
Benzinga
HeartBeam to Present at Upcoming Investor Conferences
September 29, 2022
From
HeartBeam, Inc.
Via
Business Wire
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
September 29, 2022
Gainers Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European...
Via
Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...
Via
Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Technology Enabling 12-Lead ECG Receives Patent from USPTO
September 28, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
September 28, 2022
From
HeartBeam, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 27, 2022
Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.
Via
Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
September 27, 2022
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...
Via
Benzinga
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
September 27, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 26, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.